1 |
Rahman SA, Nessa A, Hussain K.Molecular mechanisms of congenital hyperinsulinism[J].J Mol Endocrinol, 2015, 54(2):119-129.
|
2 |
Arnoux JB, Verkarre V, Saint-Martin C, et al.Congenital hyperinsulinism: current trends in diagnosis and therapy[J].Orphanet J Rare Dis, 2011, 6:63.
|
3 |
Üstün NU, Dilli D, Kundak AA, et al.A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism——a case report[J].Fetal Pediatr Pathol, 2013, 32(6):412-417.
|
4 |
Arya VB, Mohammed Z, Blankenstein O, et al.Hyperinsulinaemic hypoglycaemia[J].Horm Metab Res, 2014, 46(3):157-170.
|
5 |
Petraitien I, Barauskas G, Gulbinas A, et al.Congenital hyperinsulinism[J].Medicina (Kaunas), 2014, 50(3):190-195.
|
6 |
Su C, Gong C, Sanger P, et al. Long-term follow-up and mutation analysis of 27 Chinese cases of congenital hyperinsulinism[J]. Horm Res Paediatr, 2014, 81(3):169-176.
|
7 |
Roženková K, Güemes M, Shah P, et al.The diagnosis and management of hyperinsulinaemic hypoglycaemia[J].J Clin Res Pediatr Endocrinol, 2015, 7(2):86-97.
|
8 |
Yorifuji T, Masue M, Nishibori H.Congenital hyperinsulinism:global and Japanese perspectives[J].Pediatr Int, 2014, 56(4):467-476.
|
9 |
James C, Kapoor RR, Ismail D, et al.The genetic basis of congenital hyperinsulinism[J].J Med Genet, 2009, 46(5):289-299.
|
10 |
Flanagan SE, Kapoor RR, Hussain K.Genetics of congenital hyperinsulinemic hypoglycemia[J].Semin Pediatr Surg, 2011, 20(1):13-17.
|
11 |
Barthlen W. Surgery in congenital hyperinsulinism-tips and tricks not only for surgeons. A practical guide[J].Semin Pediatr Surg, 2011, 20(1):56-59.
|
12 |
Arnoux JB, De Lonlay P, Ribeiro MJ, et al.Congenital hyperinsulinism[J].Early Hum Dev, 2010, 86(5):287-294.
|
13 |
Dillon PA.Congenital hyperinsulinism[J].Curr Opin Pediatr, 2013, 25(3):357-361.
|
14 |
Hussain K, Flanagan SE, Smith VV, et al.An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism[J].Diabetes, 2008, 57(1):259-263.
|
15 |
Shah P, Demirbilek H, Hussain K.Persistent hyperinsulinaemic hypoglycaemia in infancy[J].Semin Pediatr Surg, 2014, 23(2):76-82.
|
16 |
Yorifuji T.Congenital hyperinsulinism: current status and future perspectives[J].Ann Pediatr Endocrinol Metab, 2014, 19(2):57-68.
|
17 |
罗飞宏.先天性高胰岛素血症诊治进展[J].中华儿科杂志,2015,53(6):468-471.
|
18 |
Gopal-Kothandapani JS, Hussain K.Congenital hyperinsulinism: role of florine-18L-3, 4 hydroxyphenylalanine positron emission tomography scanning[J].World J Radiol, 2014, 6(6):252-260.
|
19 |
Hussain K, Blankenstein O, De Lonlay P, et al.Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management[J].Arch Dis Child, 2007, 92(2):568-570.
|
20 |
Arya VB, Senniappan S, Guemes M, et al.Neonatal hypoglycemia[J].Indian J Pediatr, 2014, 81(1):58-65.
|
21 |
Edwards TM, Spatz DL.Congenital hyperinsulinism: exclusive human milk and breastfeeding[J].Adv Neonatal Care, 2014, 14(4):262-266.
|
22 |
Palladino AA, Stanley CA.A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism[J].Semin Pediatr Surg, 2011, 20(1):32-37.
|
23 |
黄佳,陈超.新生儿先天性高胰岛素血症的治疗进展[J].中国实用儿科杂志,2015,30(2):116-120.
|
24 |
Yorifuji T, Kawakita R, Hosokawa Y, et al.Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism[J].Clin Endocrinol (Oxf), 2013, 78(6):891-897.
|
25 |
Laje P, Halaby L, Adzick NS, et al.Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism[J].Pediatr Diabetes, 2010, 11(2):142-147.
|
26 |
Durmaz E, Flanagan SE, Parlak M.A combination of nifedipine and octreotide treatment in a hyperinsulinemic hypoglycemic infant[J].J Clin Res Pediatr Endocrinol, 2014, 6(2):119-121.
|
27 |
Le Quan Sang KH, Arnoux JB, Mamoune A, et al.Successful treatment of congenital hyperinsulinism with long-acting release octreotide[J].Eur J Endocrinol, 2012, 166(2):333-339.
|
28 |
Senniappan S, Alexandrescu S, Tatevian N, et al.Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia[J].N Engl J Med, 2014, 370(12):1131-1137.
|
29 |
Calabria AC, Li C, Gallagher PR, et al.GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel[J].Diabetes, 2012, 61(10):2585-2591.
|
30 |
Martin GM, Chen PC, Devaraneni P, et al.Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels[J].Front Physiol, 2013, 4:386.
|
31 |
Yan FF, Casey J, Shyng SL.Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex[J].J Biol Chem, 2006, 281(44):33403-33413.
|
32 |
Chen PC, Olson EM, Zhou Q, et al.Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism[J]. J Biol Chem, 2013, 288(29):20942-20954.
|